Becton Dickinson gains amid reports it's evaluating separating life sciences unit
Becton Dickinson (BDX) rose 2.4% in premarket trading as reports surface of potential separation of its $30 billion life sciences segment.
Becton Dickinson looks to divest life sciences unit at $30 billion valuation, source says
U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of about $30 billion, a person familiar with the matter said on Monday. The company could announce the separation of the business,
Starboard pushes medical device maker Becton Dickinson to spin off unit
Activist investor Starboard Value has taken a stake in Becton Dickinson and is pushing the $72bn medical technology company to sell its life sciences division, according to people familiar with the matter.
Becton Dickinson stock rises on activist stake report
Shares of Becton Dickinson and Co (NYSE:BDX) climbed 3.3% following news that activist investor Starboard Value has acquired a stake in the medical technology company.
Starboard takes stake in Becton Dickinson, urges spinoff of unit, FT reports
Starboard Value has taken a stake in Becton Dickinson (BDX) and is pushing the medical technology company to sell its life sciences division,
Starboard Value pushes Becton Dickinson to sell life sciences unit, FT reports
Activist investor Starboard Value has taken a stake in Becton Dickinson and is pushing the medical technology company to sell its life sciences unit, the Financial Times reported on Monday. Shares of the company were up nearly 3% in premarket trading.
Becton Dickinson Plans Life Sciences Segment Separation
Medical device maker Becton Dickinson & Co. is considering a potential separation of its life sciences segment, which could be valued at about $30 billion, according to people familiar with the matter.
Becton Dickinson (NYSE:BDX) Ticks All The Boxes When It Comes To Earnings Growth
So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Becton Dickinson (NYSE:BDX). Even if this company is fairly valued by the ...
Masimo taps Becton Dickinson executive Katie Szyman as CEO
Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after ...
Becton Dickinson & Co. stock outperforms competitors on strong trading day
This was the stock's third consecutive day of gains.
Insights Into Becton Dickinson (BDX) Q1: Wall Street Projections for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Becton Dickinson (BDX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared ...
Becton, Dickinson and Company (NYSE:BDX) Receives Average Recommendation of “Buy” from Analysts
Shares of Becton, Dickinson and Company (NYSE:BDX – Get Free Report) have earned an average rating of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat.com reports ...
Becton Dickinson price target raised to $280 from $275 at Piper Sandler
Piper Sandler raised the firm’s price target on Becton Dickinson (BDX) to $280 from $275 and keeps an Overweight rating on the shares. The firm ...
bovnews4d
Becton Dickinson and Co (BDX) Stock Posted a Gross Margin of 45.36% Over the Past Year: Is This Justifiable?
Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $249.08 which represents a slight increase of $0.38 or 0.15% from the prior close of $248.7. The stock opened at $248.68 and ...